The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 19, 2023
Filed:
Jul. 27, 2022
Applicant:
Medtronic Ireland Manufacturing Unlimited Company, Dublin, IE;
Inventors:
Gabriel Lazarus, Santa Rosa, CA (US);
Douglas A. Hettrick, Andover, MN (US);
Assignee:
Medtronic Ireland Manufacturing Unlimited Company, Dublin, IE;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 18/00 (2006.01); A61F 7/12 (2006.01); G16H 20/60 (2018.01); A61B 17/32 (2006.01); G16H 20/40 (2018.01); A61B 18/02 (2006.01); A61B 18/14 (2006.01);
U.S. Cl.
CPC ...
A61B 18/00 (2013.01); A61F 7/12 (2013.01); G16H 20/40 (2018.01); G16H 20/60 (2018.01); A61B 18/1492 (2013.01); A61B 2017/320069 (2017.08); A61B 2018/00434 (2013.01); A61B 2018/00511 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/0212 (2013.01); A61F 2007/126 (2013.01);
Abstract
Methods for treating eating disorders and for reducing a risk associated with developing an eating disorder in patients via therapeutic renal neuromodulation and associated systems. Renal sympathetic nerve activity can be attenuated to improve a patient's eating disorder status or risk of developing an eating disorder. The attenuation can be achieved, for example, using an intravascularly positioned catheter carrying a therapeutic assembly configured to modulate the renal sympathetic nerve.